Advertiment
Güth U, Kilic N, Schmid S.
Frauenklinik, Universitätsspital Basel.
Abstract
In the last years, incurable oncologic diseases have become increasingly viewed as chronic disease processes. In order to evaluate the treatment course of a chronic disease and to demonstrate whether the concept of a palliative oncologic situation as a chronic disease can be translated into practice, it is essential to give an overview of the entire course of the disease (i.e. from the first diagnosis of recurrence/metastases to death). There are only few reports regarding this approach in the international literature. We present Swiss long-term data (1990-2007) for breast and ovarian cancer and demonstrate drawbacks and opportunities of an exact retrospective data collection and analysis. When an incurable disease which requires periodic therapy cycles to control progressive course and symptoms is increasingly treated with a strategy that permits stabilization and uses regimens that have limited cumulative toxicity with particular consideration of quality of life, then the requirements of a chronic disease management have been fulfilled.
Leave a Reply
Suggested Posts
Two Cancer-Promoting Pathways Linked In Esophageal Cancer Güth U, Kilic N, Schmid S. Fraue kli ik, U iversitätsspital Basel. Abstract I the last years, i curable o cologic diseases have become i creasi gly viewed as chro ic disease processes. I order to evaluate the treatme t course of a chro ic disease a d to demo strate whether the co cept of a palliative o cologic situatio as a chro ic disease ca be tra slated i to [...]. Posted November 16th, 2010 | 4:46 pm
GSK announces positive vote from FDA panel for pazopanib in certain advanced soft tissue sarcomas Güth U, Kilic N, Schmid S. Fraue kli ik, U iversitätsspital Basel. Abstract I the last years, i curable o cologic diseases have become i creasi gly viewed as chro ic disease processes. I order to evaluate the treatme t course of a chro ic disease a d to demo strate whether the co cept of a palliative o cologic situatio as a chro ic disease ca be tra slated i to [...]. Posted November 16th, 2010 | 4:46 pm
FDA To Review Potential New Use Of XGEVA® (Denosumab) At Oncologic Drugs Advisory Committee Meeting Güth U, Kilic N, Schmid S. Fraue kli ik, U iversitätsspital Basel. Abstract I the last years, i curable o cologic diseases have become i creasi gly viewed as chro ic disease processes. I order to evaluate the treatme t course of a chro ic disease a d to demo strate whether the co cept of a palliative o cologic situatio as a chro ic disease ca be tra slated i to [...]. Posted November 16th, 2010 | 4:46 pm
FDA Approves Incyte’s Jakafi(TM) (Ruxolitinib) for Patients With Myelofibrosis Güth U, Kilic N, Schmid S. Fraue kli ik, U iversitätsspital Basel. Abstract I the last years, i curable o cologic diseases have become i creasi gly viewed as chro ic disease processes. I order to evaluate the treatme t course of a chro ic disease a d to demo strate whether the co cept of a palliative o cologic situatio as a chro ic disease ca be tra slated i to [...]. Posted November 16th, 2010 | 4:46 pm
Glucose Necessary For Cancer Growth May Prove To Be Its Weak Link Güth U, Kilic N, Schmid S. Fraue kli ik, U iversitätsspital Basel. Abstract I the last years, i curable o cologic diseases have become i creasi gly viewed as chro ic disease processes. I order to evaluate the treatme t course of a chro ic disease a d to demo strate whether the co cept of a palliative o cologic situatio as a chro ic disease ca be tra slated i to [...]. Posted November 16th, 2010 | 4:46 pm